Funding news
Violet Therapeutics logo

Violet Therapeutics Secures $4.8M Seed Funding

Recently funded · $4.8M SeedHospitals and Health CareUSView source

Get the full Violet Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Mapping cell-to-cell communication to unlock new drug targets for CNS diseases, Violet Therapeutics has raised $4.8M in seed capital.

The pre-clinical stage company, co-founded in 2021 by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital, is leveraging its first-in-class platforms to identify, map, and mine cell-to-cell communication at scale for its drug discovery programs focused on central nervous system diseases.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
LawX logo

LawX

Germany

$7.5M
2
Nof1 logo

Nof1

United States

$15.0M
3
Parcel Health logo

Parcel Health

United States

$1.2M
4
Envoke logo

Envoke

Canada

$1.6M
5
H2CHP Limited logo

H2CHP Limited

United Kingdom

$1.5M